Study of associations of blood proteins with development of unstable atherosclerotic plaques in coronary arteries by quantitative proteomics
Authors:
- E. M. StakhnevaESE. M. Stakhneva
- E. V. KashtanovaEKE. V. Kashtanova
- Ya. V. PolonskayaYPYa. V. Polonskaya
- E. V. StriukovaESE. V. Striukova
- V. S. ShramkoVSV. S. Shramko
- Е. В. СадовскийЕСЕ. В. Садовский
- A. V. KurguzovAKA. V. Kurguzov
- I. S. MurashovIMI. S. Murashov
- A. M. ChernyavskiiACA. M. Chernyavskii
- Yu. I. RaginoYu. I. Ragino
Open Access
- 21 January 2023
- journal article
- research article
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 21 (4) , 121-129-129
Abstract
Aim. To study the associations of blood proteins with the presence of unstable atherosclerotic plaques in the arteries in patients with coronary artery disease using the quantitative proteomic analysis.Materials and methods. The study included patients with coronary artery disease (n = 40); the average age of patients was 58 ± 7 years. Material for the study was blood serum. Protein concentrations in serum samples were determined using the PeptiQuant Plus Proteomics Kit (Cambridge Isotope Laboratories, USA). Protein fractions were identified using the liquid chromatograph and tandem mass spectrometer Q-TRAP 6500.Results. Mass spectrometry revealed an increased concentration of proteins, such as fibrinogen, fibulin-1, and complement factor H, in the serum samples of patients with unstable atherosclerotic plaques. It took place with a simultaneous decrease in the levels of α 2-antiplasmin, heparin cofactor II, coagulation factor XII, plasminogen, prothrombin, vitronectin, complement proteins (C1, C3, C7, C9), and complement factor B. The differences were considered significant at p < 0.05. It was revealed that the presence of unstable atherosclerotic plaques was associated with the level of fibulin-1 (Exp(B) = 1.008; р = 0.05), plasminogen (Exp(В) = 0.995; р = 0.027), and coagulation factor X (Exp(В) = 0.973; р = 0.037).Conclusion. An increased concentration of fibulin-1 can be considered as a potential biomarker of unstable atherosclerotic plaque development in coronary artery disease. The possibility of using the studied proteins as biomarkers of unstable atherosclerotic plaques requires further studies on their potential role in the development of this disease.Keywords
This publication has 21 references indexed in Scilit:
- Complement and platelets: Mutual interference in the immune networkMolecular Immunology, 2015
- The role of complement activation in atherogenesis: the first 40 yearsImmunologic Research, 2015
- Thrombosis formation on atherosclerotic lesions and plaque ruptureJournal of Internal Medicine, 2014
- Complement factor C5a induces atherosclerotic plaque disruptionsJournal of Cellular and Molecular Medicine, 2014
- Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin SystemCancer Research, 2012
- Lack of Complement Inhibitors in the Outer Intracranial Artery Aneurysm Wall Associates with Complement Terminal Pathway ActivationThe American Journal of Pathology, 2010
- Coagulation Factors II, V, IX, X, XI, and XII, Plasminogen, and α-2 Antiplasmin and Risk of Coronary Heart DiseaseJournal of Atherosclerosis and Thrombosis, 2010
- Complement Regulator CD59 Protects Against Atherosclerosis by Restricting the Formation of Complement Membrane Attack ComplexCirculation Research, 2009
- Interaction Between the Coagulation and Complement System2008
- Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat modelBiological Chemistry, 2008